![Ross A. Levine](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Ross A.
Levine is the founder of Auron Therapeutics, Inc. founded in 2018.
He is currently the President of Aquakleen Products, Inc.
Aktive Positionen von Ross A. Levine
Unternehmen | Position | Beginn |
---|---|---|
Aquakleen Products, Inc.
![]() Aquakleen Products, Inc. Miscellaneous Commercial ServicesCommercial Services Aquakleen Products, Inc. manufactures water refining products. Its products include Aquapro 5000 SXT, Aquopro + 5000 SXT, Aquaclear 5000 SXT and reverse osmosis. The company is headquartered in Costa Mesa, CA. | Präsident | 02.12.2009 |
Ehemalige bekannte Positionen von Ross A. Levine
Unternehmen | Position | Ende |
---|---|---|
Auron Therapeutics, Inc.
![]() Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auron Therapeutics, Inc. operates as a biotechnology company. It aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells. The company was founded by Kate Yen, Matt Vander Heiden, Ross Levine, and Eytan Stein and is headquartered in Wellesley, MA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Aquakleen Products, Inc.
![]() Aquakleen Products, Inc. Miscellaneous Commercial ServicesCommercial Services Aquakleen Products, Inc. manufactures water refining products. Its products include Aquapro 5000 SXT, Aquopro + 5000 SXT, Aquaclear 5000 SXT and reverse osmosis. The company is headquartered in Costa Mesa, CA. | Commercial Services |
Auron Therapeutics, Inc.
![]() Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auron Therapeutics, Inc. operates as a biotechnology company. It aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells. The company was founded by Kate Yen, Matt Vander Heiden, Ross Levine, and Eytan Stein and is headquartered in Wellesley, MA. | Commercial Services |